News
Featured News
We’re Attending ISSCR
June 03, 2022
Experience Elixirgen at 2022 ISSCR We are happy to announce that we will attendance at the Global Stem Cell Event in San Francisco, CA USA. The four day event, June 15-18th, will unite industry members across all regions to embrace innovation. Members of the science and biotechnology industry will travel from more than 65 countries […]
Featured News
Partnering at BIO International Convention
May 27, 2022
BIO2022 We are thrilled to partner at BIO International Conference, June 13-16th, hosted at San Diego Convention Center. Renown thought leaders, Olympian Venus Williams and Emmy-nominated sports broadcaster Erin Andrews, will share their patient perspectives at the world’s largest global biotech convention. The conference hosted by Biotechnology Innovation Organization is the largest biotechnology conference this […]
Featured News
Ricoh to strengthen support for drug discovery services using mRNA. Agreement reached with Elixirgen Scientific, a biotechnology company, to acquire additional shares
May 17, 2022
TOKYO, May 17, 2022 – Ricoh Company, Ltd. and Elixirgen Scientific, Inc. (Baltimore, Maryland, USA) announce that they have agreed and signed a contract for Ricoh to acquire a majority stake in Elixirgen Scientific. Ricoh had previously acquired 34.5% of Elixirgen Scientific’s stock in 2019. By having Elixirgen Scientific as its subsidiary, Ricoh aims to […]
Featured News
Product Launch: Quick-Glia™ Astrocyte – SeV Kit
April 20, 2021
The Quick-Glia™ Astrocyte – SeV Kit facilitates rapid and efficient differentiation of human iPS or ES cells into astrocyte cells. Quick-Glia™ Astrocyte differentiated cell cultures display typical astrocyte morphology and markers such as S100 Calcium Binding Protein ß (S100ß), Chondroitin Sulfate Proteoglycan 8 (CD44), Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1), and mature astrocyte marker […]
All News
Filter By Year
We’re Attending The Neuro4D Conference 2022
May 5, 2022
We are attending the Neuro4D Conference 2022. The international conference is a two day event (May 16-17) in which drug discovery experts, academic experts, service providers, and pharma strategists and investors gather in Mainz, Germany. The Neuro4D Conference 2022 focuses on 4D’s: Neuro Degenerative Disease Drug Discovery. This year will be highlighting new insights […]
Sales Partnership with Swift Scientific
April 8, 2022
We are excited to announce that Swift Scientific will now be Elixirgen Scientific’s sales representative in the Northeastern US territory. Together we anticipate business expansion with wider support in the region to better serve our valued clients. Visit Swift Scientific website here.
Product Launch: Quick-Neuron™ Precursor – mRNA Kit (Small)
August 11, 2021
Quick-Neuron™ Precursor differentiated cell cultures continue to proliferate and express a variety of NPC markers, such as nestin (NES), vimentin (VIM), Hes Family BHLH Transcription Factor 5 (HES5), SRY-Box Transcription Factor 1 (SOX1), and SRY-Box Transcription Factor 2 (SOX2). Differentiation achieved in just 6 days Proprietary transcription factor-based stem cell differentiation No genetic footprint Viable […]
Product Launch: Quick-Neuron™ Excitatory – mRNA Kit (Small)
July 8, 2021
Quick-Neuron™ Excitatory differentiated cell cultures display typical neurite outgrowth and express a variety of neuronal markers, such as tubulin beta 3 class III (TUBB3) and a variety of Excitatory neuron markers such as vesicular glutamate transporter 1 (VGLUT1) and vesicular glutamate transporter 2 (VGLUT2). • Differentiation achieved in just 10 days• Proprietary transcription factor-based stem […]
Product Launch: Quick-Neuron™ Sensory – mRNA Kit (Small)
June 16, 2021
Our Quick-Neuron™ Sensory differentiated cell cultures display typical neurite outgrowth and express a variety of neuronal markers, such as tubulin beta 3 class III (TUBB3) and variety of sensory neuron markers such as peripherin (PRPH), islet-1 (ISL1), and brain-specific homeobox/POU domain protein 3A (BRN3A/POU4F1). • Differentiation achieved in just 10 days • Proprietary transcription factor-based […]
Product Launch: Quick-Neuron™ Precursor-Human iPSC-derived Neural Precursor Cells
April 29, 2021
Our Quick-Neuron™ Precursor – Human iPSC-derived Neural Precursor Cells (NPCs) proliferate and express a variety of NPC markers, such as neuroectodermal stem cell marker, Nestin (NES) and Vimentin (VIM). • Available from multiple healthy and patient iPSC lines • Proprietary transcription factor-based stem cell differentiation • No genetic footprint • Viable long-term • Suitable for […]
